Background: In spite of the progress that was recorded in the development of anticancer drugs, challenges continue to rises particularly due to resistance of the cancer chemotherapies and low sensitivity of the commercially available anticancer drugs. Methodology: collection and...
Open access
Research Article10.9734/ajbgmb/2018/v1i2471
Farida Jazuli Usman, Dikshat Gopal Gupta, Sarki A Abdulkadir, Ibrahim Muhammad Usman, Adamu Jibrin Alhassan, Young A Yoo, Haris Jaafar Bello, Binta G. Kurfi & Kamaluddeen Babagana·Asian Journal of Biochemistry, Genetics and Molecular Biology·2025
Despite advancements in the treatment of advanced prostate cancer, including metastatic castration-resistant prostate cancer (mCRPC), the disease remains lethal, often developing resistance to conventional therapies such as androgen deprivation therapy (ADT) and chemotherapy. The...
Open access
Research Article10.9734/ajbgmb/2025/v17i1434